BIO-RAD LABORATORIES, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Bio Rad Laboratories, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $208M, a 576% increase year-over-year.
  • Bio Rad Laboratories, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$227M, a 711% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2023 was -$213M, a 80.2% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.08B, a 190% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2021 was $1.19B, a 8.25% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$227M $208M +$178M +576% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 -$404M -$621M -$283M -83.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$121M $107M +$91.3M +575% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$213M $78.7M -$185M -70.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 -$27.9M $30.8M +$75.4M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 -$103M -$338M -$43.1M -14.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$60.2M $15.9M +$1.02B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$1.08B $264M +$725M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 -$1.8B -$44.5M -$1.14B -104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 -$663M -$295M -$538M -222% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$126M -$1B -$1.32B -413% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.19B -$462M -$704M -291% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $1.9B $1.09B +$725M +196% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $1.17B $243M -$36.9M -13.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $1.21B $320M +$107M +50.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $1.1B $242M +$95.9M +65.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $1.01B $370M +$446M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $562M $280M +$109M +63.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $453M $213M -$49.3M -18.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $502M $146M +$359M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $144M -$76.4M -$157M -195% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $301M $171M +$98.7M +137% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $202M $262M +$55.2M +26.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $147M -$213M -$176M -478% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $323M $80.8M +$72.3M +848% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $251M $72M +$76M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $175M $207M +$199M +2575% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$24.5M -$36.8M -$27.3M -287% Oct 1, 2017 Dec 31, 2017 10-K 2018-04-16
Q3 2017 $2.84M $8.52M +$2.92M +52.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$81K -$3.92M -$14.2M -138% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $14.1M $7.73M -$1.47M -15.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.6M -$9.5M -$18.1M -211% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $33.7M $5.6M -$2.45M -30.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $36.1M $10.3M -$817K -7.35% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $36.9M $9.2M +$324K +3.65% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $36.6M $8.57M +$1.86M +27.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 $34.7M $8.05M -$2.92M -26.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $37.7M $11.1M -$6.05M -35.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $43.7M $8.88M +$1.01M +12.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $42.7M $6.71M -$7.67M -53.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $50.4M $11M +$9.08M +482% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $41.3M $17.2M +$2.72M +18.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $38.6M $7.87M +$4M +103% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $34.6M $14.4M -$4.92M -25.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $39.5M $1.88M -$10.5M -84.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $50M $14.4M -$3.01M -17.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $53M $3.88M -$11.4M -74.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $64.4M $19.3M -$4.71M -19.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $69.1M $12.4M +$2.47M +24.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $66.6M $17.5M -$343K -1.93% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $66.9M $15.2M -$88K -0.57% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $67M $24M +$34.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 $32.3M $9.91M -$2.91M -22.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $35.2M $17.8M +$964K +5.73% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $34.2M $15.3M +$896K +6.21% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $33.3M -$10.7M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $12.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $16.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $14.4M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.